scholarly article | Q13442814 |
P50 | author | Gilean McVean | Q5561586 |
Peter Donnelly | Q7173699 | ||
Jiannis Ragoussis | Q30004226 | ||
Stefano Lise | Q56902088 | ||
Andrea H Németh | Q64481570 | ||
Gerton Lunter | Q30089920 | ||
Alexander Kanapin | Q37391394 | ||
Jean-Baptiste Cazier | Q40034925 | ||
P2093 | author name string | David Bentley | |
Chris Allan | |||
Ian Baker | |||
Sandeep Jayawant | |||
M Zameel Cader | |||
David Buck | |||
Lorna Gregory | |||
Iain Mathieson | |||
Mandy Jackson | |||
Samantha J L Knight | |||
Ricardo Parolin Schnekenberg | |||
Sarah Hughes | |||
Daumante Suminaite | |||
Emma Perkins | |||
Gerardine Quaghebeur | |||
Richard J E Armstrong | |||
Elham Sadighi Akha | |||
Jenny C Taylor | |||
Alexandra Kwasniewska | |||
Andrew Rimmer | |||
Angie Green | |||
Sarah Lamble | |||
Jilly Hope | |||
Yvonne Clarkson | |||
P2860 | cites work | A widely expressed betaIII spectrin associated with Golgi and cytoplasmic vesicles | Q22008043 |
Ensembl 2011 | Q24614810 | ||
Fast and accurate short read alignment with Burrows-Wheeler transform | Q24653853 | ||
PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
AnkyrinG is required for clustering of voltage-gated Na channels at axon initial segments and for normal action potential firing | Q24682474 | ||
A method and server for predicting damaging missense mutations | Q27860835 | ||
Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins | Q28204174 | ||
Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads | Q28296838 | ||
Targeted deletion of betaIII spectrin impairs synaptogenesis and generates ataxic and seizure phenotypes | Q28505969 | ||
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data | Q29547161 | ||
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm | Q29547194 | ||
BEDTools: a flexible suite of utilities for comparing genomic features | Q29547332 | ||
Distribution and intensity of constraint in mammalian genomic sequence | Q29614574 | ||
Cerebellar contributions to cognition. | Q52204023 | ||
Clinical and MRI findings in spinocerebellar ataxia type 5 | Q57970943 | ||
dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation | Q33711169 | ||
Dindel: accurate indel calls from short-read data | Q33730088 | ||
Identifying a high fraction of the human genome to be under selective constraint using GERP++. | Q33769754 | ||
Loss of beta-III spectrin leads to Purkinje cell dysfunction recapitulating the behavior and neuropathology of spinocerebellar ataxia type 5 in humans. | Q33801655 | ||
Close interrelation of motor development and cognitive development and of the cerebellum and prefrontal cortex. | Q33932498 | ||
Hereditary spherocytosis | Q34014255 | ||
Beta-III spectrin mutation L253P associated with spinocerebellar ataxia type 5 interferes with binding to Arp1 and protein trafficking from the Golgi. | Q34083706 | ||
Dominant-negative mutations in alpha-II spectrin cause West syndrome with severe cerebral hypomyelination, spastic quadriplegia, and developmental delay | Q34116923 | ||
Spectrin mutations cause spinocerebellar ataxia type 5. | Q34486967 | ||
Cell organization, growth, and neural and cardiac development require αII-spectrin | Q35630638 | ||
Spinocerebellar ataxia type 5: clinical and molecular genetic features of a German kindred. | Q35639571 | ||
β-III spectrin is critical for development of purkinje cell dendritic tree and spine morphogenesis | Q36031082 | ||
mGluR5 regulates glutamate-dependent development of the mouse somatosensory cortex | Q37352265 | ||
The spectrin-ankyrin-4.1-adducin membrane skeleton: adapting eukaryotic cells to the demands of animal life | Q37776425 | ||
Brain spectrin: of mice and men. | Q40530033 | ||
Molecular epitopes of the ankyrin-spectrin interaction. | Q41162064 | ||
Distinct contributions of the hippocampus and medial prefrontal cortex to the "what-where-when" components of episodic-like memory in mice | Q41431979 | ||
Spectrin self-association site: characterization and study of beta-spectrin mutations associated with hereditary elliptocytosis | Q41807590 | ||
The Human Gene Mutation Database: providing a comprehensive central mutation database for molecular diagnostics and personalized genomics | Q42416347 | ||
When is the hippocampus involved in recognition memory? | Q48122500 | ||
Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex. | Q48241666 | ||
Sca5 or lincoln ataxia? | Q48462911 | ||
Abraham lincoln may have had sca type 5. | Q48462921 | ||
Should spinocerebellar ataxia type 5 be called Lincoln ataxia? | Q48828197 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e1003074 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | PLOS Genetics | Q1893441 |
P1476 | title | Recessive mutations in SPTBN2 implicate β-III spectrin in both cognitive and motor development | |
P478 | volume | 8 |
Q47986694 | A Japanese SCA5 family with a novel three-nucleotide in-frame deletion mutation in the SPTBN2 gene: a clinical and genetic study |
Q46249608 | A Novel Homozygous Mutation in SPTBN2 Leads to Spinocerebellar Ataxia in a Consanguineous Family: Report of a New Infantile-Onset Case and Brief Review of the Literature. |
Q37493127 | Autosomal dominant SCA5 and autosomal recessive infantile SCA are allelic conditions resulting from SPTBN2 mutations |
Q92698968 | Axonal Spectrins: Nanoscale Organization, Functional Domains and Spectrinopathies |
Q57243851 | Between SCA5 and SCAR14: delineation of the SPTBN2 p.R480W-associated phenotype |
Q38258082 | CANPMR syndrome and chromosome 1p32-p31 deletion syndrome coexist in two related individuals affected by simultaneous haplo-insufficiency of CAMTA1 and NIFA genes |
Q99248256 | CHIP as a therapeutic target for neurological diseases |
Q92920694 | Cataloguing and Selection of mRNAs Localized to Dendrites in Neurons and Regulated by RNA-Binding Proteins in RNA Granules |
Q38915057 | Cerebellar ataxias: β-III spectrin's interactions suggest common pathogenic pathways |
Q40843083 | Choice of transcripts and software has a large effect on variant annotation |
Q39866746 | Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis |
Q36066674 | De novo point mutations in patients diagnosed with ataxic cerebral palsy. |
Q36147983 | Factors influencing success of clinical genome sequencing across a broad spectrum of disorders |
Q38415567 | Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing |
Q90644138 | Heterozygous STUB1 missense variants cause ataxia, cognitive decline, and STUB1 mislocalization |
Q90364903 | MTSS1/Src family kinase dysregulation underlies multiple inherited ataxias |
Q33935986 | Mutant β-III spectrin causes mGluR1α mislocalization and functional deficits in a mouse model of spinocerebellar ataxia type 5. |
Q49542410 | Neurometabolic disorders: Five new things |
Q37200324 | Next generation sequencing for molecular diagnosis of neurological disorders using ataxias as a model |
Q38156424 | Next-generation sequencing in childhood disorders |
Q58716570 | Novel candidate genes and variants underlying autosomal recessive neurodevelopmental disorders with intellectual disability |
Q39134814 | Overcoming the divide between ataxias and spastic paraplegias: Shared phenotypes, genes, and pathways. |
Q27303788 | PMPCA mutations cause abnormal mitochondrial protein processing in patients with non-progressive cerebellar ataxia |
Q64044238 | Paradigm for disease deconvolution in rare neurodegenerative disorders in Indian population: insights from studies in cerebellar ataxias |
Q38373464 | Posterior cerebellar Purkinje cells in an SCA5/SPARCA1 mouse model are especially vulnerable to the synergistic effect of loss of β-III spectrin and GLAST. |
Q55060164 | Progressive SCAR14 with unclear speech, developmental delay, tremor, and behavioral problems caused by a homozygous deletion of the SPTBN2 pleckstrin homology domain. |
Q34071914 | Role of the axonal initial segment in psychiatric disorders: function, dysfunction, and intervention |
Q37663386 | Systematic review of autosomal recessive ataxias and proposal for a classification |
Q89144607 | Targeted exome analysis identifies the genetic basis of disease in over 50% of patients with a wide range of ataxia-related phenotypes |
Q38125937 | The application of next-generation sequencing in the autozygosity mapping of human recessive diseases |
Q39064570 | The genetic basis of cerebral palsy |
Q33568623 | Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden |
Q40942109 | β-III spectrin underpins ankyrin R function in Purkinje cell dendritic trees: protein complex critical for sodium channel activity is impaired by SCA5-associated mutations. |
Q38747497 | βIII Spectrin Is Necessary for Formation of the Constricted Neck of Dendritic Spines and Regulation of Synaptic Activity in Neurons |
Search more.